Filing Flows

Filing Flows › BeOne Medicines (ONC) › Next earnings date

BeOne Medicines (ONC) earnings: beat the estimate

BeOne Medicines (ONC) reported on Nov 5, 2026 and beat the EPS estimate: $3.28 against $1.88 (+74.3%). Revenue was $1.9B for Q3 2026, +34% year over year. It beat the EPS estimate in 80% of the quarters on record.

Last result+74.3% vs estimate
Beat rate80%

The last report

BeOne Medicines reported revenue of $1.9B for the third quarter 2026 (+34% Y/Y), net earnings $385M: Product revenue, net $1.9B, BAITUOWEI $22.1M, POBEVCY $10.7M. How it makes money → · Every quarter →

BeOne Medicines: EPS against the estimate, last 5 reportsBeOne Medicines: EPS against the estimate, last 5 reportsEstimateReported$0.86$1.09Nov 25$1.30$0.58Feb 26$0.81$1.96May 26$1.63$2.05Aug 26$1.88$3.28Nov 26
Latest (Nov 26): Estimate $1.88, Reported $3.28.
ONC: the stock's move on each reportONC: the stock's move on each reportAug 5, 2026+2.1%May 6, 2026+6.6%Feb 26, 2026-10.0%Nov 6, 2025-0.4%

BeOne Medicines' latest quarter

BeOne Medicines, Q3 2026: revenue $1.9B (+34% year over year), operating margin 22.2%, net earnings $385M, operating cash flow $509M. The chart follows the revenue to costs, profit and cash.

Questions

Did BeOne Medicines beat earnings?

BeOne Medicines (ONC) reported on Nov 5, 2026 and beat the EPS estimate: $3.28 against $1.88 (+74.3%).

When does ONC report earnings?

The next date is not set yet.

Does BeOne Medicines usually beat earnings?

It beat the consensus EPS estimate in 80% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.